Ingrid Delaet

Ingrid Delaet

Conseiller Juridique Général chez NEUROCRINE BIOSCIENCES, INC.

Fortune : 1 M $ au 30/04/2024

58 ans
Health Technology
Consumer Services

Provenance du réseau au premier degré de Ingrid Delaet

EntitéType d'entitéIndustrie
Public Company Pharmaceuticals: Major 25
Public Company Pharmaceuticals: Major 25

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Ingrid Delaet via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Pharmaceuticals: Major

Klaus Veitinger

Richard Pops

Daniel Bradbury

Director/Board Member

Director/Board Member

Director/Board Member

Biotechnology

Stephen Sherwin

William Rastetter

Gary Lyons

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Sales & Marketing

College/University

Rachel McMinn

Ryan Sullivan

Bryan Yoon

Undergraduate Degree

Undergraduate Degree

Graduate Degree

TERNS PHARMACEUTICALS, INC. Biotechnology

Mark Vignola

Senthil Sundaram

Bryan Yoon

Director of Finance/CFO

Chief Executive Officer

Chief Operating Officer

Biotechnology

Jonathan Silverstein

Keith Gottesdiener

Director/Board Member

Chief Executive Officer

ELI LILLY AND COMPANY Pharmaceuticals: Major

Eiry Roberts

Jude Onyia

Corporate Officer/Principal

Corporate Officer/Principal

IMMUNOMEDICS, INC. Biotechnology

Barbara Duncan

Bryan Ball

Director/Board Member

Corporate Officer/Principal

SCPHARMACEUTICALS INC. Pharmaceuticals: Major

Klaus Veitinger

Jonathan Silverstein

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Daniel Bradbury

Christian Weyer

Director/Board Member

President

RELYPSA INC Pharmaceuticals: Major

Klaus Veitinger

Jonathan Silverstein

Director/Board Member

Director/Board Member

University of Pennsylvania College/University

Keith Gottesdiener

Linda M. Richardson

Doctorate Degree

Undergraduate Degree

INSEAD College/University

Klaus Veitinger

David Ford

Masters Business Admin

Masters Business Admin

Investment Managers

Klaus Veitinger

Jonathan Silverstein

Private Equity Investor

Private Equity Investor

Pharmaceuticals: Generic

Shalini Sharp

Nancy Miller-Rich

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Shalini Sharp

Malcolm C. Lloyd-Smith

Human Resources Officer

General Counsel

RHYTHM PHARMACEUTICALS, INC. Biotechnology

Jonathan Silverstein

Keith Gottesdiener

Director/Board Member

Chief Executive Officer

VOLCANO CORPORATION Medical Specialties

Darin Lippoldt

Leslie Norwalk

Compliance Officer

Director/Board Member

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Christine Poon

Johanna Mercier

Corporate Officer/Principal

Corporate Officer/Principal

Medical Distributors

Sandipkumar S. Kapadia

Rocco Venezia

Chief Executive Officer

Chief Executive Officer

Pharmaceuticals: Major

Dimitri Grigoriadis

Malcolm C. Lloyd-Smith

Corporate Officer/Principal

General Counsel

Medical Distributors

Sandipkumar S. Kapadia

Rocco Venezia

Director/Board Member

Director/Board Member

JOHNSON & JOHNSON Pharmaceuticals: Major

Christine Poon

Leah Neufeld

Director/Board Member

Human Resources Officer

ILLUMINA, INC. Biotechnology

William Rastetter

Daniel Bradbury

Chairman

Director/Board Member

FATE THERAPEUTICS, INC. Biotechnology

William Rastetter

Christian Weyer

Chairman

Chief Executive Officer

Medical/Nursing Services

Senthil Sundaram

Bryan Yoon

Director/Board Member

Director/Board Member

Harvard College College/University

Shalini Sharp

Keith Gottesdiener

Undergraduate Degree

Undergraduate Degree

NIGHTSTAR THERAPEUTICS PLC Pharmaceuticals: Major

Senthil Sundaram

Bryan Yoon

Director of Finance/CFO

General Counsel

AVANIR PHARMACEUTICALS INC Pharmaceuticals: Major

Jonathan Silverstein

Eric Benevich

Director/Board Member

Public Communications Contact

ASCENDIS PHARMA A/S Pharmaceuticals: Major

Jonathan Silverstein

Lisa Bright

Director/Board Member

Director/Board Member

University of California, Los Angeles College/University

Kevin Gorman

Kyle Gano

Doctorate Degree

Doctorate Degree

Pharmaceuticals: Major

Keith Gottesdiener

Nancy Miller-Rich

Corporate Officer/Principal

Corporate Officer/Principal

GELESIS INC Biotechnology

Klaus Veitinger

Jonathan Silverstein

Director/Board Member

Chairman

College/University

George Morrow

Mark Vignola

Masters Business Admin

Graduate Degree

Miscellaneous Commercial Services

Daniel Bradbury

Christian Weyer

Director/Board Member

President

Pharmaceuticals: Major

Daniel Bradbury

Jonathan Silverstein

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Stephen Sherwin

Richard Pops

Chairman

Director/Board Member

BIOGEN INC. Pharmaceuticals: Major

Stephen Sherwin

William Rastetter

Director/Board Member

Chief Executive Officer

Miscellaneous Commercial Services

Daniel Bradbury

Matthew Abernethy

Director/Board Member

Director/Board Member

RIGEL PHARMACEUTICALS, INC. Pharmaceuticals: Major

Stephen Sherwin

Gary Lyons

Director/Board Member

Chairman

Harvard Medical School College/University

Stephen Sherwin

Richard Pops

Doctorate Degree

Corporate Officer/Principal

GILEAD SCIENCES, INC. Biotechnology

Lisa Bright

Johanna Mercier

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Lisa Bright

Sandipkumar S. Kapadia

Corporate Officer/Principal

Director/Board Member

Pharmaceuticals: Major

David Shapiro

Keith Gottesdiener

Director/Board Member

Corporate Officer/Principal

Miscellaneous Commercial Services

Richard Pops

Linda M. Richardson

Director/Board Member

Sales & Marketing

Statistiques

Internationale

Etats-Unis 44
Royaume-Uni 5
France 2
Allemagne 2
Danemark 2

Sectorielle

Health Technology 30
Commercial Services 9
Consumer Services 8
Finance 4
Distribution Services 3

Opérationnelle

Director/Board Member 278
Independent Dir/Board Member 113
Corporate Officer/Principal 105
Chairman 50
Undergraduate Degree 43
  1. Bourse
  2. Insiders
  3. Ingrid Delaet
  4. Connexions Sociétés
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT